Cargando…

Made in Europe: will artemisinin resistance emerge in French Guiana?

Resistance to artemisinin casts a shadow on the fight against malaria. The importance of illegal gold miners and of malaria in isolated regions of French Guiana constitutes a threat that endangers the fight against malaria in the Amazon. The hurdles of French laws and the remoteness of the territory...

Descripción completa

Detalles Bibliográficos
Autores principales: Nacher, Mathieu, Guérin, Philippe J, Demar-Pierre, Magalie, Djossou, Félix, Nosten, François, Carme, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649934/
https://www.ncbi.nlm.nih.gov/pubmed/23641802
http://dx.doi.org/10.1186/1475-2875-12-152
_version_ 1782269040650092544
author Nacher, Mathieu
Guérin, Philippe J
Demar-Pierre, Magalie
Djossou, Félix
Nosten, François
Carme, Bernard
author_facet Nacher, Mathieu
Guérin, Philippe J
Demar-Pierre, Magalie
Djossou, Félix
Nosten, François
Carme, Bernard
author_sort Nacher, Mathieu
collection PubMed
description Resistance to artemisinin casts a shadow on the fight against malaria. The importance of illegal gold miners and of malaria in isolated regions of French Guiana constitutes a threat that endangers the fight against malaria in the Amazon. The hurdles of French laws and the remoteness of the territory from France make it impossible for the system to adapt to the problem of total inaccessibility of an important part of the malaria problem. Transmission is high in these areas and gold miners self-medicate with erratic regimens of artemisinin combinations, thus creating perfect conditions for the emergence of resistance. What needs to be done is being done, but within the limits of national law, with some results. However, facing the same difficult problem, Suriname shows more flexibility and is doing much better than French Guiana despite having lower resources. Local authorities in French Guiana cannot overrule the laws that block appropriate malaria care from reaching a third of malaria-exposed persons. Thus the health authorities in France should take immediate calibrated legislative and financial measures to avoid a predictable disaster.
format Online
Article
Text
id pubmed-3649934
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36499342013-05-10 Made in Europe: will artemisinin resistance emerge in French Guiana? Nacher, Mathieu Guérin, Philippe J Demar-Pierre, Magalie Djossou, Félix Nosten, François Carme, Bernard Malar J Opinion Resistance to artemisinin casts a shadow on the fight against malaria. The importance of illegal gold miners and of malaria in isolated regions of French Guiana constitutes a threat that endangers the fight against malaria in the Amazon. The hurdles of French laws and the remoteness of the territory from France make it impossible for the system to adapt to the problem of total inaccessibility of an important part of the malaria problem. Transmission is high in these areas and gold miners self-medicate with erratic regimens of artemisinin combinations, thus creating perfect conditions for the emergence of resistance. What needs to be done is being done, but within the limits of national law, with some results. However, facing the same difficult problem, Suriname shows more flexibility and is doing much better than French Guiana despite having lower resources. Local authorities in French Guiana cannot overrule the laws that block appropriate malaria care from reaching a third of malaria-exposed persons. Thus the health authorities in France should take immediate calibrated legislative and financial measures to avoid a predictable disaster. BioMed Central 2013-05-04 /pmc/articles/PMC3649934/ /pubmed/23641802 http://dx.doi.org/10.1186/1475-2875-12-152 Text en Copyright © 2013 Nacher et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Opinion
Nacher, Mathieu
Guérin, Philippe J
Demar-Pierre, Magalie
Djossou, Félix
Nosten, François
Carme, Bernard
Made in Europe: will artemisinin resistance emerge in French Guiana?
title Made in Europe: will artemisinin resistance emerge in French Guiana?
title_full Made in Europe: will artemisinin resistance emerge in French Guiana?
title_fullStr Made in Europe: will artemisinin resistance emerge in French Guiana?
title_full_unstemmed Made in Europe: will artemisinin resistance emerge in French Guiana?
title_short Made in Europe: will artemisinin resistance emerge in French Guiana?
title_sort made in europe: will artemisinin resistance emerge in french guiana?
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649934/
https://www.ncbi.nlm.nih.gov/pubmed/23641802
http://dx.doi.org/10.1186/1475-2875-12-152
work_keys_str_mv AT nachermathieu madeineuropewillartemisininresistanceemergeinfrenchguiana
AT guerinphilippej madeineuropewillartemisininresistanceemergeinfrenchguiana
AT demarpierremagalie madeineuropewillartemisininresistanceemergeinfrenchguiana
AT djossoufelix madeineuropewillartemisininresistanceemergeinfrenchguiana
AT nostenfrancois madeineuropewillartemisininresistanceemergeinfrenchguiana
AT carmebernard madeineuropewillartemisininresistanceemergeinfrenchguiana